Previous 10 | Next 10 |
AdaptHealth (NASDAQ: AHCO ) initiated with Outperform rating and $13 (30% upside) price target at SVB Leerink. More news on: AdaptHealth Corp., CryoLife, Inc., Acadia Healthcare Company, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. GenMark Diagnostics Inc (NASDAQ: GNMK) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading
GenMark Diagnostics, Inc. (GNMK) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Leigh Salvo – Investor Relations Hany Massarany – President and Chief Executive Officer Scott Mendel – Chief Operating Officer Johnny Ek ...
GenMark Diagnostics (NASDAQ: GNMK ): Q3 GAAP EPS of -$0.20 misses by $0.01 . Revenue of $20.9M (+32.3% Y/Y) beats by $0.39M . Press Release More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news,
CARLSBAD, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2019. Highlights Recognized total reve...
CARLSBAD, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, November 6, 2019. Management will hold a conference call to review the company's fin...
Thinly traded GenMark Diagnostics ( GNMK +14.1% ) is up 15% higher volume, albeit on turnover of only 361K shares, on the heels of its Q2 report released after the close yesterday. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on ...
GenMark (NASDAQ: GNMK ) has filed to offer up to $35M in common stock. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Read more ...
GenMark Diagnostics (NASDAQ: GNMK ): Q2 GAAP EPS of -$0.23 misses by $0.03 . More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended June 30, 2019. Highlights Recognized total revenue o...
News, Short Squeeze, Breakout and More Instantly...
GenMark Diagnostics Inc. Company Name:
GNMK Stock Symbol:
NASDAQ Market:
GenMark Diagnostics Inc. Website:
NEW YORK, NY / ACCESSWIRE / April 9, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New ...
Healthcare giant Roche Holding (OTC: RHHBY) recently announced plans to acquire GenMark Diagnostics (NASDAQ: GNMK) in a deal valued at around $1.8 billion. The news sent GenMark's shares soaring close to 30%. In this Motley Fool Live video, recorded on March 17 , Mot...
USA News Group / In the wake of the US presidential election, calls for economies to reopen are beginning to mount from governors such as Andrew Cuomo in New York and Gavin Newsom in California , and mayors like Chicago’s Lori Lightfoot. As regulators contemplate the ...